Clinical Trials

Accrual Status
Limit to SWOG Trials

1037 Results

View
Status Trial Number Title Activated Closed Accrual Phase Published
Closed S1400E Lung-MAP S1400E: HGF - Rilotumumab plus Erlotinib vs. Erlotinib 6/15/2014 11/25/2014 3%
Closed S1400F Lung-MAP S1400F: Non-Match-MEDI4736 and Tremelimumab 10/2/2017 3/24/2020 51%
Closed S1400G Lung-MAP S1400G: HRRD - Talazoparib (BMN 673) 2/7/2017 7/23/2018 85%
Closed S1400I Lung-MAP S1400I: Non-Match, Nivolumab + Ipilimumab 12/18/2015 4/23/2018 79%
Closed S1400K Lung-MAP S1400K: c-MET Positive 2/5/2018 12/21/2018 64%
Closed S1800A LUNGMAP S1800A: Non-Match Immunotherapy Combination Sub-Study 5/17/2019 11/16/2020 100%
Closed S1800D LUNGMAP S1800D: Non-match Sub-Study 2/15/2022 3/10/2023 17%
Closed S1900A LUNGMAP S1900A: LOH HIGH and/or BRCA 1/2 mutation - Rucaparib 1/29/2019 73%
Closed S1900B LUNGMAP S1900B: RET Fustion Positive - LOXO-292 2/10/2020 5%
Closed S1900C LUNGMAP S1900C: STK11 - Talazoparib Plus Avelumab 1/16/2020 12/18/2020 100%
Closed S1900E LUNGMAP S1900E: KRAS Targeted Therapy Sub-Study 4/2/2021 12/27/2024 100%
Open LUNGMAP LUNGMAP Screening Protocol for NSCLC 1/28/2019
Closed SWOG-7963 m-AMSA in Melanoma, Myeloma, Lymphoma, Oat Cell Lung Carcinoma and Breast Cancer 4/20/1979 4/5/1982
Closed SWOG-8507 Maintenance versus no Maintenance BCG Immunotherapy of Superficial Bladder Cancer 12/20/1985 12/15/1988 Published
Closed SWOG-9149 Malignant Glioma 5/1/1994 2/15/2001 89% Published
Closed S0330 Malignant Peripheral Nerve Sheath Tumors 12/15/2003 1/15/2006 60% Published
Closed S0218 Malignant Pleural Mesothelioma 5/1/2002 4/1/2003 100% Published
Closed SWOG-8107 Management of Disseminated Melanoma, Master Protocol 5/26/1982 11/15/1987 Published
Closed S0213 Mantle Cell Lymphoma 10/1/2002 9/1/2006 100% Published
Closed SWOG-7820 Maytansine in Advanced Sarcoma 9/29/1978 10/19/1979
Scroll Table